131 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
7 May 24
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
8:05am
compensation strategy; and (ii) if we did not pay out a portion of our compensation in the form of stock-based compensation, the cash salary expense included
8-K
EX-99.1
bste04pd460dpk40qime
12 Mar 24
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
4:10pm
424B3
bm4136igpbnmp
5 Sep 23
Prospectus supplement
9:14pm
424B5
0neto
20 Oct 22
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.2
l99ecw099hhe1maf3908
19 Sep 22
Other Events
8:00am
8-K
EX-99.1
q6xyr 0h7
30 Jun 22
Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability
8:40am